A shadow market for unapproved slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.
Investigational Drug Acquiring Popularity Via Social Media
The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed fat-burning effects. Followers are encouraged to message these profiles privately for source information, while also obtaining promotional offers.
Active Trade on Messaging Platforms
Separately, a flourishing market exists on messaging services, where communities with thousands of members share comparison images, injection guides and claims of next-day British shipping. Vendors promote the drug there before directing customers to other platforms for purchases.
Learning About The Experimental Drug
Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Early trials suggest it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Experts Express Concerns
However, physicians and chemists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to users administering products of unknown origin.
Some professionals stated the demand for the experimental drug could be connected to the increasing price of approved weight loss treatments such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Several influencers try to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate medicines, advertising, and consumer laws, potentially leading to penalties, prosecution or prison.
Platform Response and Content Elimination
Based on TikTok, the service has removed violative content and banned related keywords and search suggestions. The organization stated it was committed to maintaining the service secure and allocating resources in strengthening enforcement strategies.
Online Marketplace Activities
Research also discovered groups with up to 9,000 members marketing retatrutide using Telegram's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly displays groups with numerous of users, populated with images of slimming results, glowing reviews and step-by-step instructions for mixing or injecting at residence.
After minutes of joining one community, a seller posted contact information, where most transactions take place. The seller provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one inquired about weight, medical conditions or past usage.
Product Details and Pricing
Inside these groups, messages display black plastic packages with Royal Mail stickers, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at home with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When asked how long a pen should last, sellers give contradictory responses ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A representative for the messaging service said it regularly monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are injecting materials they cannot confirm. Even if the research behind retatrutide is valid, these digital products may not include what they claim,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent cost increases for authorized slimming medications such as Mounjaro. “With costs rising, individuals are using online platforms. But fake treatments are highly risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she said.
Her team has already seen patients harmed by personal administration from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”
Producer Statement
A spokesperson from Eli Lilly said the substance was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they said, adding that any product “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject users to possibly significant health risks”.
